APAC

Government and private investment accelerates innovation.

Increasing cases were driven by aging populations and liver diseases.

A staffing shortage makes it harder to turn added space into fully usable beds.

Robotic-assisted surgery drives precision in complex procedures.

It is also driven by chronic diseases and biologics production.

Telehealth, 3D printing, and customisation are amongst the key trends.

He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.

Asia-Pacific will see the fastest growth.

It will be driven by nine new pipeline therapies targeting disease modification

Regulatory incentives and innovative trial designs also boost market interest.

Asia-Pacific medical costs are set to outpace global averages this year.

The industry is projected to reach $67.39b by end-period.

Market growth is driven by ML, deep learning, EHR.

The elderly population accounts for the largest share of the market.

It is driven by rising cases of bacterial, viral, and allergic conjunctivitis

US policies are driving global price pressures.